749
Participants
Start Date
January 31, 2006
Primary Completion Date
July 31, 2007
Flibanserin
flibanserin flexible dosing
511.74.01051 Boehringer Ingelheim Investigational Site, Birmingham
511.74.01027 Boehringer Ingelheim Investigational Site, Mobile
511.74.01029 Boehringer Ingelheim Investigational Site, Scottsdale
511.74.01031 Boehringer Ingelheim Investigational Site, Tucson
511.74.01004 Boehringer Ingelheim Investigational Site, Jonesboro
511.74.01053 Boehringer Ingelheim Investigational Site, Little Rock
511.74.01033 Boehringer Ingelheim Investigational Site, Palm Springs
511.74.01003 Boehringer Ingelheim Investigational Site, Palo Alto
511.74.01015 Boehringer Ingelheim Investigational Site, Sacramento
511.74.01013 Boehringer Ingelheim Investigational Site, San Diego
511.74.01052 Boehringer Ingelheim Investigational Site, Torrance
511.74.01022 Boehringer Ingelheim Investigational Site, Aurora
511.74.01046 Boehringer Ingelheim Investigational Site, Denver
511.74.01002 Boehringer Ingelheim Investigational Site, Groton
511.74.01023 Boehringer Ingelheim Investigational Site, Middlebury
511.74.01009 Boehringer Ingelheim Investigational Site, West Hartford
511.74.01035 Boehringer Ingelheim Investigational Site, Newark
511.74.01039 Boehringer Ingelheim Investigational Site, Coral Gables
511.74.01019 Boehringer Ingelheim Investigational Site, Gainesville
511.74.01044 Boehringer Ingelheim Investigational Site, Hollywood
511.74.01001 Boehringer Ingelheim Investigational Site, Hudson
511.74.01043 Boehringer Ingelheim Investigational Site, Pembroke Pines
511.74.01032 Boehringer Ingelheim Investigational Site, St. Petersburg
511.74.01036 Boehringer Ingelheim Investigational Site, Roswell
511.74.01047 Boehringer Ingelheim Investigational Site, Champaign
511.74.01038 Boehringer Ingelheim Investigational Site, Evansville
511.74.01014 Boehringer Ingelheim Investigational Site, Lexington
511.74.01007 Boehringer Ingelheim Investigational Site, Baton Rouge
511.74.01024 Boehringer Ingelheim Investigational Site, Rockland
511.74.01030 Boehringer Ingelheim Investigational Site, Ann Arbor
511.74.01056 Boehringer Ingelheim Investigational Site, Bingham Farms
511.74.01010 Boehringer Ingelheim Investigational Site, St Louis
511.74.01012 Boehringer Ingelheim Investigational Site, Billings
511.74.01045 Boehringer Ingelheim Investigational Site, Omaha
511.74.01041 Boehringer Ingelheim Investigational Site, Las Vegas
511.74.01055 Boehringer Ingelheim Investigational Site, Reno
511.74.01018 Boehringer Ingelheim Investigational Site, Poughkeepsie
511.74.01011 Boehringer Ingelheim Investigational Site, Rochester
511.74.01048 Boehringer Ingelheim Investigational Site, Winston-Salem
511.74.01021 Boehringer Ingelheim Investigational Site, Cincinnati
511.74.01042 Boehringer Ingelheim Investigational Site, Columbus
511.74.01050 Boehringer Ingelheim Investigational Site, Edmond
511.74.01006 Boehringer Ingelheim Investigational Site, Eugene
511.74.01034 Boehringer Ingelheim Investigational Site, Medford
511.74.01040 Boehringer Ingelheim Investigational Site, Pittsburgh
511.74.01017 Boehringer Ingelheim Investigational Site, Anderson
511.74.01057 Boehringer Ingelheim Investigational Site, Knoxville
511.74.01008 Boehringer Ingelheim Investigational Site, Nashville
511.74.01016 Boehringer Ingelheim Investigational Site, Plano
511.74.01020 Boehringer Ingelheim Investigational Site, San Antonio
511.74.01005 Boehringer Ingelheim Investigational Site, Salt Lake City
511.74.01026 Boehringer Ingelheim Investigational Site, Norfolk
511.74.01037 Boehringer Ingelheim Investigational Site, Renton
511.74.01028 Boehringer Ingelheim Investigational Site, Spokane
511.74.01049 Boehringer Ingelheim Investigational Site, Milwaukee
511.74.02011 Boehringer Ingelheim Investigational Site, Coquitlam
511.74.02009 Boehringer Ingelheim Investigational Site, Kelowna
511.74.02012 Boehringer Ingelheim Investigational Site, Winnipeg
511.74.02006 Boehringer Ingelheim Investigational Site, St. John's
511.74.02004 Boehringer Ingelheim Investigational Site, Halifax
511.74.02010 Boehringer Ingelheim Investigational Site, Kingston
511.74.02003 Boehringer Ingelheim Investigational Site, Oakville
511.74.02002 Boehringer Ingelheim Investigational Site, Ottawa
511.74.02007 Boehringer Ingelheim Investigational Site, Ottawa
511.74.02008 Boehringer Ingelheim Investigational Site, Montreal
Sprout Pharmaceuticals, Inc
INDUSTRY